574 related articles for article (PubMed ID: 2581301)
1. Calcium agonism, a new mechanism for positive inotropy. Hemodynamic effects and mode of action of BAY K 8644.
Schramm M; Towart R; Kazda S; Thomas G; Franckowiak G
Adv Myocardiol; 1985; 6():59-70. PubMed ID: 2581301
[TBL] [Abstract][Full Text] [Related]
2. Activation of calcium channels by novel 1,4-dihydropyridines. A new mechanism for positive inotropics or smooth muscle stimulants.
Schramm M; Thomas G; Towart R; Franckowiak G
Arzneimittelforschung; 1983; 33(9):1268-72. PubMed ID: 6196037
[TBL] [Abstract][Full Text] [Related]
3. Vascular and cardiac effects of a new dihydropyridine derivative, YC-170: a comparison with Bay K 8644.
Hattori Y; Nakaya H; Tohse N; Kanno M
J Pharmacol Exp Ther; 1986 Aug; 238(2):670-8. PubMed ID: 2426442
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular effects of the calcium-agonistic dihydropyridine BAY K 8644 in conscious dogs.
Gross R; Kayser M; Schramm M; Taniel R; Thomas G
Arch Int Pharmacodyn Ther; 1985 Oct; 277(2):203-16. PubMed ID: 2415078
[TBL] [Abstract][Full Text] [Related]
5. Calcium channel modulation: ability to inhibit or promote calcium influx resides in the same dihydropyridine molecule.
Thomas G; Gross R; Schramm M
J Cardiovasc Pharmacol; 1984; 6(6):1170-6. PubMed ID: 6084776
[TBL] [Abstract][Full Text] [Related]
6. SR 33557, a novel calcium entry blocker. I. In vitro isolated tissue studies.
Polster P; Christophe B; Van Damme M; Houlliche A; Chatelain P
J Pharmacol Exp Ther; 1990 Nov; 255(2):593-9. PubMed ID: 1700816
[TBL] [Abstract][Full Text] [Related]
7. Effects of nilvadipine on the cardiovascular system in experimental animals.
Ohtsuka M; Koibuchi Y; Sakai S; Tsujioka K; Fujiwara T; Ozaki T; Maeda K; Motoyama I; Horiai H; Ono T
Arzneimittelforschung; 1988 Nov; 38(11):1605-18. PubMed ID: 3214444
[TBL] [Abstract][Full Text] [Related]
8. Agonist actions of Bay K 8644, a dihydropyridine derivative, on the voltage-dependent calcium influx in smooth muscle cells of the rabbit mesenteric artery.
Kanmura Y; Itoh T; Kuriyama H
J Pharmacol Exp Ther; 1984 Dec; 231(3):717-23. PubMed ID: 6209390
[TBL] [Abstract][Full Text] [Related]
9. Antihypertensive and cardiovascular effects of the new dihydropyridine derivative methyl (E)-3-phenyl-2-propen-1-yl-1,4-dihydro-2,6-dimethyl- 4-(3-nitrophenyl)pyridine-3,5-dicarboxylate.
Yamaura T; Kase N; Kita H; Uematsu T
Arzneimittelforschung; 1986; 36(1):29-34. PubMed ID: 3754142
[TBL] [Abstract][Full Text] [Related]
10. Effect of the Ca(2+)-channel agonist Bay K 8644 on the contractile responses in human placental veins.
Barrús MT; Reviriego J; Marín J
J Auton Pharmacol; 1996 Jun; 16(3):161-7. PubMed ID: 8884463
[TBL] [Abstract][Full Text] [Related]
11. Effects of Bay k 8644 and nifedipine on isolated dog cerebral, coronary and mesenteric arteries.
Asano M; Aoki K; Suzuki Y; Matsuda T
J Pharmacol Exp Ther; 1987 Nov; 243(2):646-56. PubMed ID: 2445956
[TBL] [Abstract][Full Text] [Related]
12. Chronotropic, inotropic, and vasodilator actions of diltiazem, nifedipine, and verapamil. A comparative study of physiological responses and membrane receptor activity.
Millard RW; Grupp G; Grupp IL; DiSalvo J; DePover A; Schwartz A
Circ Res; 1983 Feb; 52(2 Pt 2):I29-39. PubMed ID: 6831652
[TBL] [Abstract][Full Text] [Related]
13. Pharmacology of 2-amino-1,4-dihydro-4-(2-[4-[4-(2-methoxyphenyl)-1- piperazinyl]butylsulfinyl]phenyl)-6-methyl-5-nitro-3-pyridine carboxylic acid methyl ester (XB513), a novel calcium agonist with alpha-1 adrenergic receptor antagonistic.
Wong PC; Aldrich PE; Chiu AT; Earl RA; Hart SD; Johnson AL; Ma P; McCall DE; Price WA; Smith RD
J Pharmacol Exp Ther; 1993 Jun; 265(3):1088-95. PubMed ID: 8099616
[TBL] [Abstract][Full Text] [Related]
14. [Calcium antagonists: effect on peripheral and coronary hemodynamics].
Simon R
Z Kardiol; 1984; 73 Suppl 2():79-88. PubMed ID: 6528705
[TBL] [Abstract][Full Text] [Related]
15. Contractile effects of Bay k 8644, a dihydropyridine calcium agonist, on isolated femoral arteries from spontaneously hypertensive rats.
Asano M; Aoki K; Matsuda T
J Pharmacol Exp Ther; 1986 Oct; 239(1):198-205. PubMed ID: 2428972
[TBL] [Abstract][Full Text] [Related]
16. Influence of dihydropyridine-type calcium agonists on hemodynamics and myocardial ischemia in isolated rabbit hearts.
Rump AF; Rösen R; Sigmund B; Fuchs J; Ratke R; Klaus W
Arzneimittelforschung; 1993 Oct; 43(10):1056-9. PubMed ID: 7505584
[TBL] [Abstract][Full Text] [Related]
17. Effects of nitrendipine (BAY e 5009), nifedipine, verapamil, phentolamine, papaverine, and minoxidil on contractions of isolated rabbit aortic smooth muscle.
Towart R
J Cardiovasc Pharmacol; 1982; 4(6):895-902. PubMed ID: 6185780
[TBL] [Abstract][Full Text] [Related]
18. Hemodynamic effects of the new vasodilator drug Bay k 5552 in man.
Vogt A; Neuhaus KL; Kreuzer H
Arzneimittelforschung; 1980; 30(12):2162-4. PubMed ID: 7194078
[TBL] [Abstract][Full Text] [Related]
19. The optical isomers of the 1,4-dihydropyridine BAY K 8644 show opposite effects on Ca channels.
Franckowiak G; Bechem M; Schramm M; Thomas G
Eur J Pharmacol; 1985 Aug; 114(2):223-6. PubMed ID: 2412855
[TBL] [Abstract][Full Text] [Related]
20. Stimulation of Ca-dependent action potentials in mammalian ventricular myocardium by a novel dihydropyridine.
Nilius B
Biomed Biochim Acta; 1984; 43(12):1385-97. PubMed ID: 6085472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
